Adverum Biotechnologies (ADVM) Tops Q1 EPS by 102c
Tweet
Share
E-mailGet Alerts ADVM Hot Sheet
Join SI Premium – FREE
Adverum Biotechnologies (NASDAQ: ADVM) reported Q1 EPS of ($1.50), $1.02 better than the analyst estimate of ($2.52).
For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
